🇺🇸 Glucomannan in United States

26 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Sudden Cardiac Death — 5 reports (19.23%)
  2. Diarrhoea — 3 reports (11.54%)
  3. Myocarditis — 3 reports (11.54%)
  4. Nausea — 3 reports (11.54%)
  5. Atrial Tachycardia — 2 reports (7.69%)
  6. Cardiotoxicity — 2 reports (7.69%)
  7. Cough — 2 reports (7.69%)
  8. Death — 2 reports (7.69%)
  9. Deep Vein Thrombosis — 2 reports (7.69%)
  10. Drug Ineffective — 2 reports (7.69%)

Source database →

Glucomannan in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Glucomannan approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glucomannan in United States?

Medical University of Warsaw is the originator. The local marketing authorisation holder may differ — check the official source linked above.